Patient P-02690

Synthetic patientMETA-24 · Day 177 · 25–34 · M · baseline S02Steering view · 3D Open companion preview

Therapy response

Declining

Tolerance

Improving

GI state

Favorable

Inflammatory state

Improving

Nutritional resilience

Favorable

Discontinuation risk

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S02
Day 82 ME-01 recommended — Monitoring Escalation ME-01
Day 83 Patient accepted — Started ME-01 in the companion
Day 86 Deterioration detected before clinical escalation — Monitoring Escalation ME-01

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Treatment adherence-10
Toxicity-10
Inflammatory activity-9
GI instability-3

What helped?

Monitoring Escalation ME-01Day 82
Result: deterioration detected before clinical escalation

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

39 min

improving · +2.8 vs previous 14 d

Sleep duration

Wearable

7 h

stable · -0.0 vs previous 14 d

Energy level

Daily log

6.7/10

improving · +0.5 vs previous 14 d

Steps

Wearable

4,761

improving · +203 vs previous 14 d

GI burden

Companion

3.9/100

improving · -5.7 vs previous 14 d

Adherence

Companion

87.1 %

stable · -1.5 vs previous 14 d

Sleep quality

Wearable

50.4/100

stable · +1.7 vs previous 14 d

Glucose, CGM daily mean

CGM

120 mg/dL

stable · +1.1 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards restoration · 98 from the failing basin, 18 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -3.6 next day on high-intake days · n 23

Would not help

Keep alcohol low
GI +2.2 next day on high-intake days · n 16
Keep histamine low
GI +1.6 next day on high-intake days · n 19

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-3.6supporter · 95%
Alcohol
+2.2detractor · 88%
Histamine load
+1.6detractor · 58%
Caffeine
+1.2no signal · 38%
Dietary fat load
-0.9no signal · 29%
Insoluble fibre
+0.4no signal · 15%
Ultra-processed food
-0.3no signal · 15%
Simple carbohydrates
-0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Inflammatory signalling ↓35
- MicrobiomeBacteroides fragilis expansion
- WearableHRV 38 ms, trending down
Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted

DNA

Fictional pharmacogenomic panel

CYP2D6 Normal metabolizer
Expected exposure
MTHFR C677T
Reduced folate turnover

Microbiome

Shannon diversity 3.2 · butyrate capacity 81/100

Akkermansia muciniphilaLow
Faecalibacterium prausnitziiLow
Bacteroides fragilisHigh
Bifidobacterium longumNormal
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 39 ms
Sleep: 7.2 h
Steps: 3,458
Resting HR: 71 bpm

Daily log: GI score 4, nutritional resilience 68, adherence 87.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
A 15-minute walk after lunch
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02667	44%	S08	HY-01	improved	77
P-02630	41%	S17	NP-02	improved	76
P-02415	40%	S17	GI-04	improved	86
P-02127	37%	S11	SC-12	improved	73
P-02464	37%	S18	ME-01	improved	68
P-02450	36%	S12	NP-02	improved	92
P-02486	36%	S10	ME-01	improved	86
P-02518	36%	S17	DT-01	improved	68
P-02068	35%	S14	NP-02	improved	83
P-02277	34%	S05	AD-05	improved	92
P-02441	34%	S11	SC-12	improved	67
P-02462	34%	S12	DT-01	improved	65